Talis Biomedical Stock

Talis Biomedical P/B

Delisted

The P/B (Price-to-Book Ratio) of Talis Biomedical (TLIS) as of Aug 19, 2026 is 0.07. In the previous year, P/B (Price-to-Book Ratio) was 0.04 — a change of 83.37% (higher).

P/B

0.07

YoY

83.37%

Last updated:

P/B (Price-to-Book Ratio) of Talis Biomedical is 2026 0.07 . P/B (Price-to-Book Ratio) of Talis Biomedical was 2025 0.04 . It decreases by 83.37% higher compared to the previous year.
Access this data via the Eulerpool API

Talis Biomedical Stock analysis

What does Talis Biomedical do? Talis Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Talis Biomedical stock

P/B (Price-to-Book Ratio) of Talis Biomedical is 0.07 in 2026.

P/B (Price-to-Book Ratio) of Talis Biomedical changed from 0.04 to 0.07, representing a 83.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Talis Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Talis Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Talis Biomedical

All Key Metrics — Talis Biomedical